Vascular Grafts Market Demand and Forecast 2024-2032

Global Vascular Grafts Industry: Key Statistics and Insights in 2024-2032

Summary:

• The global vascular grafts market size reached USD 1.9 Billion in 2023.

• The market is expected to reach USD 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.

• North America leads the market, accounting for the largest vascular grafts market share.

• Endovascular stent grafts account for the majority of the market share in the product segment, as they are highly effective in treating aortic aneurysms and other vascular conditions.

• Polytetrafluoroethylene (PTFE) holds the largest share in the vascular grafts industry.

• Cardiac aneurysm remains a dominant segment in the market owing to the increasing incidence of cardiovascular diseases.

• Hospitals represents the leading end user segment.

• The rising prevalence of cardiovascular diseases is a primary driver of the vascular grafts market.

• The increasing aging population is reshaping the vascular grafts market.

Industry Trends and Drivers:

• Growing aging population:

With aging, individuals are more susceptible to age-related vascular conditions, such as atherosclerosis, aneurysms, and peripheral artery disease. These conditions often require vascular interventions, including the use of vascular grafts. Older individuals often have multiple comorbidities, such as diabetes, hypertension, and heart disease, which can exacerbate vascular issues. Managing these conditions may involve vascular procedures and graft implantation. Older individuals are more likely to seek medical interventions to maintain their quality of life, which can include vascular graft procedures to address circulatory problems.

• Technological advancements:

Advancements in materials science are leading to the development of graft materials that are more biocompatible and durable. Innovations like expanded polytetrafluoroethylene (ePTFE) and bioresorbable materials enhance graft performance and longevity, making them more appealing to surgeons and patients. Technology is enabling the design of grafts with improved hemodynamics and reduced turbulence, which is essential for optimal blood flow. Advancements in tissue engineering and regenerative medicine are leading to the development of biological vascular grafts, which can promote natural tissue growth and regeneration.

• Increasing prevalence of cardiovascular diseases:

As the number of individuals diagnosed with cardiovascular diseases is rising, there is an increasing patient population in need of treatment. Many cardiovascular conditions, such as coronary artery disease and peripheral artery disease, require surgical interventions that often involve the use of vascular grafts. Vascular grafts are used in revascularization procedures to bypass or replace damaged blood vessels, restoring proper blood circulation. As cardiovascular diseases like atherosclerosis, aneurysms, and peripheral artery disease are becoming more common, the demand for effective surgical treatments, such as vascular grafts, is growing. These grafts are critical in bypass surgeries and in repairing or replacing damaged blood vessels, which is vital for patients with severe CVDs.

Request for a sample copy of this report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Vascular Grafts Market Report Segmentation:

Breakup By Product:

• Endovascular Stent Grafts

• Hemodialysis Access Grafts

• Coronary Artery By-Pass Grafts

• Vascular Grafts for Aorta Disease

• Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they offer minimally invasive (MI) alternatives for various vascular conditions, reducing patient recovery time and complications.

Breakup By Raw Material:

• Polytetrafluoroethylene (PTFE)

• Polyester

• Polyurethane

• Biosynthetic

Polytetrafluoroethylene (PTFE) accounts for the largest market share due to its biocompatibility, durability, and long history of successful use in vascular grafts.

Breakup By Application:

• Cardiac Aneurysm

• Kidney Failure

• Vascular Occlusion

• Coronary Artery Disease

Cardiac aneurysm exhibits clear dominance in the market because the cardiovascular system is particularly susceptible to aneurysms, necessitating the frequent use of vascular grafts for treatment.

Breakup By End User:

• Hospitals

• Ambulatory Surgical Centers (ASCs)

Hospitals hold the biggest market share on account of their primary healthcare institutions where a significant number of vascular procedures are performed.

Breakup By Region:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

North America enjoys the leading position in the vascular grafts market owing to its advanced healthcare infrastructure and high prevalence of cardiovascular diseases.

Top Vascular Grafts Market Leaders: The vascular grafts market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Abbott Laboratories

• B. Braun SE (B. Braun Holding GmbH & Co. KG)

• Becton, Dickinson and Company

• Cook Group Incorporated

• Cordis

• CryoLife Inc.

• Getinge AB

• Heat Medical Europe BV

• LeMaitre Vascular

• Medtronic plc

• Terumo Corporation

• W. L. Gore & Associates Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163